SNAP vs GENI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

SNAP

30.0
AI Score
VS
GENI Wins

GENI

53.8
AI Score

Investment Advisor Scores

SNAP

30score
Recommendation
AVOID NEW MONEY

GENI

54score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric SNAP GENI Winner
Forward P/E 7.6687 51.0204 SNAP
PEG Ratio 496.0591 0 Tie
Revenue Growth 18.9% 64.7% GENI
Earnings Growth 395.8% 0.0% SNAP
Tradestie Score 30.0/100 53.8/100 GENI
Profit Margin -4.9% -23.0% SNAP
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD GENI

Relative Price Performance (Last 90 Days)

SNAP 1M: -23.4% · 3M: -3.8% GENI 1M: -3.9% · 3M: -17.0%

Current Technical Phase

SNAP

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 37

RSI (14): 36.8 · Price: $5.00

GENI

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -8.2%) with fading momentum, RSI 49

RSI (14): 49.0 · Price: $6.35

Fundamentals Snapshot

Metric SNAP GENI
Market Cap — —
Forward P/E 31.6 6.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.1% 0.6%
Gross Margin 0.6% 0.3%
Operating Margin 0.0% 0.1%
EPS -0.09 -0.61
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GENI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.